| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
|
J Clin Oncol
|
2006
|
2.60
|
|
2
|
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.
|
Cancer Res
|
2002
|
2.21
|
|
3
|
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
|
J Clin Oncol
|
2003
|
2.05
|
|
4
|
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment.
|
J Transl Med
|
2006
|
1.98
|
|
5
|
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.
|
Clin Cancer Res
|
2010
|
1.87
|
|
6
|
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.
|
J Am Coll Surg
|
2010
|
1.70
|
|
7
|
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
|
Clin Cancer Res
|
2006
|
1.68
|
|
8
|
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
|
Surgery
|
2007
|
1.67
|
|
9
|
Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
|
Cancer
|
2002
|
1.65
|
|
10
|
Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.
|
J Clin Endocrinol Metab
|
2009
|
1.62
|
|
11
|
Regional treatment options for patients with ocular melanoma metastatic to the liver.
|
Ann Surg Oncol
|
2004
|
1.55
|
|
12
|
Reoperation for parathyroid adenoma: a contemporary experience.
|
Surgery
|
2009
|
1.50
|
|
13
|
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.
|
Int J Cancer
|
2007
|
1.43
|
|
14
|
Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging.
|
Biotechniques
|
2003
|
1.36
|
|
15
|
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases.
|
Cancer
|
2003
|
1.36
|
|
16
|
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
|
Clin Cancer Res
|
2013
|
1.31
|
|
17
|
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
|
PLoS One
|
2012
|
1.30
|
|
18
|
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy.
|
Clin Cancer Res
|
2008
|
1.29
|
|
19
|
Successful outcome after surgical management in two cases of the "painful variant" of Hashimoto's thyroiditis.
|
Endocr Pract
|
2002
|
1.25
|
|
20
|
Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
|
Cancer Res
|
2003
|
1.22
|
|
21
|
Using gene expression profiling to differentiate benign versus malignant thyroid tumors.
|
Cancer Res
|
2004
|
1.21
|
|
22
|
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.
|
Mol Ther
|
2004
|
1.21
|
|
23
|
Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?
|
Ann Surg
|
2004
|
1.20
|
|
24
|
Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.
|
Blood
|
2002
|
1.20
|
|
25
|
Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
|
Ann Surg
|
2003
|
1.20
|
|
26
|
A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.
|
Oncology
|
2011
|
1.18
|
|
27
|
Malignant insulinoma: spectrum of unusual clinical features.
|
Cancer
|
2005
|
1.07
|
|
28
|
Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure.
|
J Am Coll Surg
|
2002
|
1.07
|
|
29
|
Surgical treatment of malignant peritoneal mesothelioma: past, present, and future.
|
Ann Surg Oncol
|
2010
|
1.07
|
|
30
|
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.
|
J Clin Oncol
|
2005
|
1.06
|
|
31
|
Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma.
|
J Natl Compr Canc Netw
|
2012
|
1.06
|
|
32
|
A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas.
|
Surgery
|
2005
|
1.06
|
|
33
|
Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma.
|
Cancer
|
2010
|
1.02
|
|
34
|
Role of metastasectomy in the management of thyroid carcinoma: the NIH experience.
|
J Surg Oncol
|
2003
|
1.01
|
|
35
|
Pseudo-Meigs' syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literature.
|
Gynecol Oncol
|
2004
|
1.00
|
|
36
|
Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI.
|
Mol Imaging
|
2002
|
1.00
|
|
37
|
Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
|
J Bone Miner Res
|
2002
|
1.00
|
|
38
|
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts.
|
Int J Cancer
|
2002
|
0.99
|
|
39
|
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
|
Int J Cancer
|
2013
|
0.99
|
|
40
|
Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
|
Radiology
|
2002
|
0.98
|
|
41
|
Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
|
Surgery
|
2003
|
0.97
|
|
42
|
A novel nomogram for peritoneal mesothelioma predicts survival.
|
Ann Surg Oncol
|
2012
|
0.96
|
|
43
|
Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures.
|
World J Surg
|
2003
|
0.96
|
|
44
|
Targeting vaccinia to solid tumors with local hyperthermia.
|
Hum Gene Ther
|
2005
|
0.95
|
|
45
|
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.
|
Hum Gene Ther
|
2006
|
0.95
|
|
46
|
Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
|
Cancer Res
|
2003
|
0.95
|
|
47
|
Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells.
|
Ann Surg Oncol
|
2006
|
0.94
|
|
48
|
Transarterial perfusion of liver metastases.
|
Semin Oncol
|
2002
|
0.93
|
|
49
|
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia.
|
Surgery
|
2008
|
0.92
|
|
50
|
Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
|
Ann Surg Oncol
|
2007
|
0.92
|
|
51
|
Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.
|
J Transl Med
|
2005
|
0.91
|
|
52
|
Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
|
Cytokine
|
2005
|
0.91
|
|
53
|
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.
|
Ann Surg Oncol
|
2008
|
0.90
|
|
54
|
Management and outcome of patients with sporadic gastrinoma arising in the duodenum.
|
Ann Surg
|
2003
|
0.90
|
|
55
|
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
|
Clin Nucl Med
|
2012
|
0.90
|
|
56
|
Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism.
|
Surgery
|
2002
|
0.89
|
|
57
|
A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
|
Surgery
|
2005
|
0.89
|
|
58
|
Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis.
|
PLoS One
|
2012
|
0.88
|
|
59
|
The past decade of experience with isolated hepatic perfusion.
|
Oncologist
|
2004
|
0.88
|
|
60
|
Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism.
|
Cancer Res
|
2004
|
0.87
|
|
61
|
Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas.
|
Ann Surg Oncol
|
2005
|
0.87
|
|
62
|
The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism.
|
Surgery
|
2008
|
0.87
|
|
63
|
Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.
|
Ann Surg Oncol
|
2008
|
0.86
|
|
64
|
A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay.
|
J Transl Med
|
2004
|
0.85
|
|
65
|
Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients.
|
Pathology
|
2014
|
0.85
|
|
66
|
FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.
|
Cancer Res
|
2013
|
0.85
|
|
67
|
Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
|
Int J Oncol
|
2003
|
0.84
|
|
68
|
Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
|
Pathology
|
2013
|
0.83
|
|
69
|
Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases.
|
J Gastrointest Oncol
|
2013
|
0.83
|
|
70
|
Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.
|
Surgery
|
2004
|
0.82
|
|
71
|
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
|
Surgery
|
2012
|
0.82
|
|
72
|
Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
|
Ann Surg Oncol
|
2010
|
0.82
|
|
73
|
Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion.
|
J Gastrointest Surg
|
2005
|
0.81
|
|
74
|
Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.
|
Surg Oncol Clin N Am
|
2008
|
0.81
|
|
75
|
Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.
|
J Gastrointest Surg
|
2004
|
0.81
|
|
76
|
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
|
Cancer Chemother Pharmacol
|
2007
|
0.81
|
|
77
|
TNF-based isolated hepatic perfusion.
|
Front Biosci (Landmark Ed)
|
2009
|
0.79
|
|
78
|
Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?
|
Am J Med
|
2007
|
0.79
|
|
79
|
Isolation perfusion of the liver.
|
Cancer J
|
2002
|
0.79
|
|
80
|
Current role of hepatic artery infusion and isolated liver perfusion for the treatment of colorectal cancer liver metastases.
|
Cancer J
|
2004
|
0.79
|
|
81
|
The impact of major surgery on blood coagulation factors and thrombin generation.
|
Am J Hematol
|
2007
|
0.78
|
|
82
|
Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.
|
Ann Surg
|
2012
|
0.78
|
|
83
|
Hyperthermia and its modern use in cancer treatment.
|
Cancer
|
2003
|
0.77
|
|
84
|
Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia.
|
Int J Cancer
|
2004
|
0.77
|
|
85
|
Development of a melanoma-specific adenovirus.
|
Mol Ther
|
2002
|
0.76
|
|
86
|
Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction.
|
J Clin Oncol
|
2012
|
0.76
|
|
87
|
Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.
|
Med Oncol
|
2014
|
0.76
|
|
88
|
Gastrinoma: sporadic and familial disease.
|
Surg Oncol Clin N Am
|
2006
|
0.75
|
|
89
|
Hyperthermic isolated hepatic perfusion for the treatment of unresectable cancers confined to the liver.
|
J Surg Oncol
|
2002
|
0.75
|
|
90
|
Surgery for peritoneal mesothelioma.
|
Curr Treat Options Oncol
|
2011
|
0.75
|
|
91
|
A motion for cautious optimism in the treatment of patients with ocular melanoma: the ayes have it.
|
Ann Surg Oncol
|
2005
|
0.75
|
|
92
|
Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas.
|
Surgery
|
2003
|
0.75
|
|
93
|
Regional therapies for cancer.
|
Ann Surg Oncol
|
2013
|
0.75
|
|
94
|
Rapid measurement of insulin using the Abbott IMx: application to the management of insulinoma.
|
Ann Clin Biochem
|
2002
|
0.75
|
|
95
|
Isolated hepatic perfusion: treating unresectable liver metastases.
|
Adv Exp Med Biol
|
2006
|
0.75
|